Incepto Medical raises $16M to expand access to AI in medical imaging

Incepto Medical raises $16M to expand access to AI in medical imaging

Latest Medtech News


Incepto Medical, a Paris-based medical imaging AI platform, has closed a $16 million financing round led by impact fund Impactivist, with continued participation from existing investors LBO France, Karista, BPI France, and Wille Finance. As part of the round, Incepto is establishing an Impact Committee within its governance structure to measure the company's contribution across four areas: patients, healthcare professionals, equitable access to AI, and trust in AI.

As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Subscribe to our Industry Insights for weekly coverage.

Founded in 2018, Incepto serves more than 1,000 medical centers across ten countries, supporting AI-assisted imaging exams for 6 million patients annually. The company reports its platform contributes to detecting close to 2,000 additional breast cancer cases per year that would otherwise be missed, a 27% reduction in emergency department length of stay through faster triage, and a four-week reduction in wait times for complex exams like prostate MRI. Its customer base includes major European healthcare groups such as Helios, Affidea, Unilabs, and CUF, alongside global distribution partnerships supporting expansion into the US market.

The new funding will support scaling of TANGO, Incepto's generative AI reporting assistant, across Europe and the US, strengthen post-market surveillance capabilities, expand its curated portfolio of AI applications, and fund targeted acquisitions.

For Incepto, the round and its accompanying governance structure formalize impact measurement as a defined business discipline rather than a marketing claim. For the broader MedTech space, the deal reflects continued attention to equitable AI deployment, addressing the disparity between AI adoption concentrated in large expert centers and the radiologist shortages more acute in regional hospitals and smaller practices.

CEO Antoine Jomier said the company's focus has shifted from proving that AI works in imaging to determining "who it reaches and whether it can be trusted."

Go Back

We'd love to hear what you're building